Intended for healthcare professionals


Novartis agrees to pay $390m in US kickback case

BMJ 2015; 351 doi: (Published 28 October 2015) Cite this as: BMJ 2015;351:h5784
  1. Michael McCarthy
  1. 1Seattle

Novartis AG, the Swiss drug company, has agreed to pay $390m (£255m; €352m) to settle a lawsuit in which the US government claimed that the company had paid kickbacks to specialty pharmacies to boost sales of its drugs.

The lawsuit filed by the US Department of Justice had initially sought $3.35bn in fines and damages, charging that the kickback …

View Full Text

Log in

Log in through your institution


* For online subscription